XORTX Therapeutics Inc. filed a Form 6-K on April 30, 2025, indicating compliance with SEC reporting requirements. The company reported its registration under Form 20-F for annual reports.
AI Assistant
XORTX THERAPEUTICS INC
2025
6 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.